1. Home
  2. GTE vs QNCX Comparison

GTE vs QNCX Comparison

Compare GTE & QNCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gran Tierra Energy Inc.

GTE

Gran Tierra Energy Inc.

N/A

Current Price

$4.84

Market Cap

163.1M

Sector

Energy

ML Signal

N/A

Logo Quince Therapeutics Inc.

QNCX

Quince Therapeutics Inc.

N/A

Current Price

$2.98

Market Cap

167.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GTE
QNCX
Founded
2003
2012
Country
Canada
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
163.1M
167.0M
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
GTE
QNCX
Price
$4.84
$2.98
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$7.67
AVG Volume (30 Days)
589.5K
753.4K
Earning Date
02-23-2026
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$611,444,000.00
N/A
Revenue This Year
$4.87
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.09
$0.72
52 Week High
$8.04
$4.55

Technical Indicators

Market Signals
Indicator
GTE
QNCX
Relative Strength Index (RSI) 62.44 47.18
Support Level $4.69 $2.85
Resistance Level $5.12 $3.15
Average True Range (ATR) 0.24 0.24
MACD 0.09 -0.05
Stochastic Oscillator 75.45 43.00

Price Performance

Historical Comparison
GTE
QNCX

About GTE Gran Tierra Energy Inc.

Gran Tierra Energy Inc is an independent energy company. The company, along with its subsidiaries, is focused on oil and gas exploration and production, with assets in Colombia, Canada, and Ecuador. It produces oil, natural gas, and natural gas liquids. Gran Tierra has assembled a diversified, high-quality asset base that is fully operated in Colombia and Ecuador and partly in Canada. The company operates various blocks in Colombia and Ecuador, spanning three basins. It also has contiguous areas in Alberta, Canada, spanning various gross acres across the Western Canadian Sedimentary Basin. The company's reportable segments are Colombia, Ecuador, Canada, and Other. A majority of its revenue is derived from its operations in Colombia.

About QNCX Quince Therapeutics Inc.

Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.

Share on Social Networks: